HaMPCs: Additional Phase I/IIa data

Additional data from a double-blind, Chinese Phase I/IIa trial in 18 patients with OA of the knee showed that 2 intra-articular injections of ReJoin given 3 weeks apart reduced WOMAC scores by 9.92 po...